Libra Therapeutics is advancing new therapeutics to improve lysosomal function with the potential to halt neurodegeneration in amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's, Parkinson's, Huntington's disease, and more
Libra Therapeutics is advancing new therapeutics to improve lysosomal function with the potential to halt neurodegeneration in amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's, Parkinson's, Huntington's disease, and more.